STOCK TITAN

Nutex Health (NUTX) director gains 603 shares via RSU conversion

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nutex Health director Michael Lee Reed reported the conversion of restricted stock units into 603 shares of Common Stock on July 31, 2026, at a stated price of $0.0000 per share. The shares are held indirectly through the Michael L Reed Trust IRA (MLRTIRA), bringing his reported indirect holdings to 670 shares. The transaction was not reported as made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Reed Michael Lee
Role Director
Type Security Shares Price Value
Exercise Common Stock F1, F2 603 $0.00 $0.00
Holdings After Transaction: Common Stock — 670 shares (Indirect, See note (2))
Footnotes (2)
  1. F1. Restricted stock units convert into common shares on a one-for-one basis.
  2. F2. Michael L Reed Trust IRA ("MLRTIRA"), the direct beneficial owner of 67 shares of Common Stock. Michael L Reed, the sole trustee of MLRTIRA, is the indirect beneficial owner of such shares.
Shares acquired 603 shares Restricted stock units converted into Common Stock on July 31, 2026
Indirect holdings after transaction 670 shares Common Stock indirectly owned through Michael L Reed Trust IRA (MLRTIRA)
Conversion price $0.0000 per share Stated price for RSU conversion to Common Stock
RSU conversion ratio 1-to-1 Restricted stock units convert into common shares on a one-for-one basis
Restricted stock units financial
"Restricted stock units convert into common shares on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
indirect beneficial owner financial
"is the indirect beneficial owner of such shares."
sole trustee financial
"Michael L Reed, the sole trustee of MLRTIRA, is the indirect"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transaction did Nutex Health (NUTX) director Michael Lee Reed report on this Form 4?

He reported the conversion of restricted stock units into 603 shares of Nutex Health Common Stock on July 31, 2026, at a stated price of $0.0000 per share, increasing his indirect ownership through the Michael L Reed Trust IRA.

How many Nutex Health (NUTX) shares does Michael Lee Reed report owning after this transaction?

After the transaction, Reed reports indirect beneficial ownership of 670 Nutex Health shares. These shares are held by the Michael L Reed Trust IRA (MLRTIRA), where he serves as sole trustee and is therefore the indirect beneficial owner of the trust’s holdings.

What type of securities were involved in Michael Lee Reed’s Nutex Health (NUTX) Form 4 filing?

The filing involves restricted stock units (RSUs) that convert into Nutex Health Common Stock on a one-for-one basis. In this event, RSUs converted into 603 common shares, which were then reflected as indirectly owned through the MLRTIRA trust structure.

How are the Nutex Health (NUTX) shares in this Form 4 held for Michael Lee Reed?

The 670 Nutex Health shares are held by the Michael L Reed Trust IRA ("MLRTIRA") as the direct beneficial owner. Michael Lee Reed is the sole trustee of MLRTIRA and is reported as the indirect beneficial owner of those shares through the trust.

Was Michael Lee Reed’s Nutex Health (NUTX) Form 4 transaction under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the transaction was not affirmed as being under a Rule 10b5-1 trading plan, meaning it was not reported as executed pursuant to a pre-arranged automatic trading program and instead is disclosed as a discretionary RSU conversion event.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reed Michael Lee

(Last)(First)(Middle)
1776 YORKTOWN STREET SUITE 700
C/O NUTEX HEALTH INC.

(Street)
HOUSTON TEXAS 77056

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026M603A$0(1)670ISee note (2)(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units convert into common shares on a one-for-one basis.
2. Michael L Reed Trust IRA ("MLRTIRA"), the direct beneficial owner of 67 shares of Common Stock. Michael L Reed, the sole trustee of MLRTIRA, is the indirect beneficial owner of such shares.
/s/ Michael Reed08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)